Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea

Figure 3

Mean changes from baseline BCVA and CRT in various group analyses. (a) and (b) Treatment naïve versus nonnaïve eyes; (c) and (d) phakic versus pseudophakic eyes; (e) and (f) nonvitrectomized versus vitrectomized eyes; (g) and (h) absence of SRF versus presence of SRF; (i) and (j) focal versus diffuse DME.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)